Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
February 20, 2024 07:30 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
February 15, 2024 16:05 ET
|
Vaxcyte, Inc.
SAN CARLOS, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
Growing Applications in Pharmaceutical and Food and Beverage Industries to Surge Chromatography Instrumentation Market at 5.6% CAGR by 2034 | Future Market Insights, Inc.
February 09, 2024 08:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 09, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI), the global chromatography instrumentation market is expected to grow from US$ 10.3 billion in 2024 to US$...
Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 02, 2024 18:39 ET
|
Vaxcyte, Inc.
SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
February 01, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Influenza Vaccine Market Analysis & Forecast Report 2024: Advanced R&D Initiatives Poised to Catalyze Growth Through 2034
January 31, 2024 09:18 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccine Market Analysis & Forecast 2024-2034: Market By Vaccine Type; By Indication; By Age Group; By Route of Administration; By...
Veteran ABC News Correspondent John Quiñones to Speak at The Immunization Partnership 2024 Annual Dinner
January 31, 2024 08:55 ET
|
The Immunization Partnership
HOUSTON, TX, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The Immunization Partnership (TIP), a statewide nonprofit committed to a healthy Texas, is proud to welcome San Antonio native and award-winning ABC...
Vaxcyte Announces Pricing of $750 Million Public Offering
January 30, 2024 23:37 ET
|
Vaxcyte, Inc.
SAN CARLOS, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
January 30, 2024 16:01 ET
|
Vaxcyte, Inc.
SAN CARLOS, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
Global Influenza Vaccines Market Poised for Growth: Projected to Surge to USD 13.7 Billion by 2032
January 30, 2024 05:00 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccines Market and Forecasts 2024 - 2032" report has been added to ResearchAndMarkets.com's offering. The global influenza...